Insider plans sale of 10,349 FENC common shares

An insider associated with FENC has filed a notice of intent to sell 10,349 common shares through Morgan Stanley Smith Barney LLC on or around 02/02/2026, with the shares to be sold on NASDAQ.

Rhea-AI Filing Summary

An insider associated with FENC has filed a notice of intent to sell 10,349 common shares through Morgan Stanley Smith Barney LLC on or around 02/02/2026, with the shares to be sold on NASDAQ.

The shares were acquired the same day via a stock option exercise paid in cash. Over the prior three months, the same seller, Rostislav Raykov, sold additional blocks of common stock totaling 30,312 shares for gross proceeds of about $235,000. The issuer had 28,116,829 shares outstanding when this notice was prepared.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the latest Form 144 filing for FENC disclose?

The filing discloses an insider’s intent to sell 10,349 common shares of FENC through Morgan Stanley Smith Barney LLC around 02/02/2026 on NASDAQ. These shares were acquired the same day via a cash stock option exercise from the issuer.

Who is selling shares in the FENC Form 144 and how many?

The seller named is Rostislav Raykov, who plans to sell 10,349 common shares of FENC. The sale is to be executed through Morgan Stanley Smith Barney LLC, using its Executive Financial Services division at 1 New York Plaza, New York.

How were the FENC shares being sold in this Form 144 acquired?

The 10,349 FENC common shares to be sold were acquired on 02/02/2026 via a stock option exercise from the issuer. Payment for these shares was made in cash on the same date, according to the Form 144 disclosure table.

What prior FENC share sales has this insider reported in the last 3 months?

Over the past three months, Rostislav Raykov reported three FENC common stock sales: 10,000 shares on 11/05/2025, 10,000 shares on 12/05/2025, and 10,312 shares on 01/02/2026, for total gross proceeds of roughly $235,000.

What is the aggregate market value and share count context in the FENC Form 144?

The planned sale of 10,349 common shares has an aggregate market value of about $80,339.29. The issuer reported 28,116,829 shares outstanding when this notice was prepared, providing context for the relative size of the proposed sale.

On which exchange will the FENC shares in this Form 144 be sold?

The Form 144 states that the 10,349 common shares of FENC are expected to be sold on the NASDAQ market. The executing broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, New York.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:32 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001468316
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	FENNEC PHARMACEUTICALS INC.
SEC File Number	001-32295
Address of Issuer	PO BOX 13628, 68 TW ALEXANDER DRIVE Research Triangle Park NORTH CAROLINA 27709
Phone	(919) 636-4530
Name of Person for Whose Account the Securities are To Be Sold	ROSTISLAV RAYKOV
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	10349	80339.29	28116829	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/02/2026	Stock Option Exercise	ISSUER			10349	02/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ROSTISLAV RAYKOV PO BOX 13628, 68 TW ALEXANDER DRIVE Research Triangle Park NC 27709	Common	12/05/2025	10000	75443.99
ROSTISLAV RAYKOV PO BOX 13628, 68 TW ALEXANDER DRIVE Research Triangle Park NC 27709	Common	11/05/2025	10000	81082.00
ROSTISLAV RAYKOV PO BOX 13628, 68 TW ALEXANDER DRIVE Research Triangle Park NC 27709	Common	01/02/2026	10312	78471.23

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/19/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Rostislav Raykov
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)